Skip to main content

Major Drug Companies Agree to Price Negotiations With U.S. Government

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

TUESDAY, Oct. 3, 2023 -- Pharmaceutical companies that make the 10 prescription drugs chosen to be the first for price negotiations for Medicare patients have agreed to talks with the government.

The Biden administration announced Tuesday that the drugmakers, including Merck, Bristol Myers Squibb and Johnson & Johnson, will take part in price negotiations despite ongoing lawsuits over this same requirement, NBC News reported.

This negotiation is a component of the Inflation Reduction Act, which allows Medicare to work with the drug companies to reduce prices for older Americans. Negotiations are to occur next year with resulting prices going into effect in 2026.

The first 10 drugs named by the Centers for Medicare and Medicaid Services include diabetes drug Januvia, Enbrel for rheumatoid arthritis, and the blood thinners Eliquis and Xarelto.

Last year, about 9 million Medicare enrollees paid $3.4 billion out of pocket for these 10 specific drugs, NBC News reported.

Additional drugs will later be added to negotiations.

The federal government had given manufacturers one month to decide if they would participate in talks or face tax penalties, NBC News reported. Drugmakers could avoid the penalty if they removed their drug from the Medicare program, but that, too, could be costly.

Companies who are suing, including Merck and Johnson & Johnson, have said that allowing negotiations could affect their profits and as a result, spending on research and development.

Medicare provides health insurance to more than 65 million older Americans.

Sources

  • NBC News, Oct. 3, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted October 2023

Read this next

AI Might Spot Rare Diseases in Patients Years Earlier

FRIDAY, May 3, 2024 -- Artificial intelligence might be able to identify patients who have rare diseases years earlier than they would typically be diagnosed, a new study says. A...

Does Preschool Boost Kids' Long-Term Academic Success? Study Finds Mixed Results

FRIDAY, May 3, 2024 -- Pre-kindergarten programs have long been considered an early ticket to future success for children. But the evidence is much more mixed than one might...

Even Skipping Meat for One Meal Helps Liver Disease Patients

FRIDAY, May 3, 2024 -- Advanced liver cirrhosis can push levels of ammonia in the blood to hazardous levels, but skipping meat at mealtime can help reverse that, new research...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.